Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Sign in
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Emerging Approaches in Schizophrenia
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
View All
Céline Dubath, PharmD
JCP
Original Research
Daily Dose Effects of Risperidone on Metabolic Parameters
May 9, 2022
This study investigated whether dose is a factor in the development of metabolic side effects with atypical antipsychotics.
Marianna Piras
,
Céline Dubath
,
Mehdi Gholam
, et al
JCP
Original Research
Cardiometabolic Health in Psychiatry
March 31, 2020
Psychiatric patients are susceptible to cardiovascular disease (CVD), but this risk is poorly understood. This study compared CVD risk in psychiatric patients taking weight gain-inducing drugs with that in...
Céline Dubath
,
Aurélie Delacrétaz
,
Anaׯs Glatard
, et al
JCP
Original Research
Lipid Worsening in Adolescents Treated With SGAs
April 9, 2019
How bad is too bad? Lipid worsening of 5% or more in the early stages of treatment with SGAs predicts a negative metabolic outcome in adults. Is it the...
Aurélie Delacrétaz
,
Frederik Vandenberghe
,
Anaׯs Glatard
, et al
